NCT00002375View on ClinicalTrials.gov

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Nelfinavir mesylate

Trial Locations (3)

15261

Univ of Pittsburgh / Graduate School of Public Health, Pittsburgh

35294

Univ of Alabama at Birmingham, Birmingham

92103

UCSD Treatment Ctr / Dept of Medicine and Pediatrics, San Diego

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY